Press-release for stocks for rgnx

Prices are updated after-hours

FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
Published: 2021-10-27 (Crawled : 20:00) - fda.gov
TMO | News | $574.59 4.78% -1.12% 2.5M

| -10.44% | O: 0.44% H: 2.01% C: 0.82%
TAK | News | $13.38 0.15% 0.9% 1.7M

| -3.33% | O: 2.03% H: 3.33% C: 0.07%
RGNX | $15.885 1.57% 1.54% 360K

| -55.59% | O: 0.91% H: 2.93% C: 2.79%
BIIB | $193.18 -0.48% -0.48% 1.4M

| -25.33% | O: 0.19% H: 2.32% C: 1.7%
disease fda gene therapies therapy gene therapy rare

78%

22%

MTTR | News 4 | $4.6 164.37% 62.17% 28M

AGBA | $2.94 135.2% 57.48% 66M

EDBL | News | $6.46 71.81% 41.8% 2M

MTC | $2.25 44.23% 30.67% 6M

OPRT | News | $3.175 41.11% 29.13% 12M

SHIM | $3.05 35.56% 26.23% 1.1M

HKIT | $1.345 31.86% 24.16% 390K

ABVC | $1.36 30.77% 23.53% 7.4M

OST | $0.512 28.0% 21.88% 290K

POET | $1.59 27.2% 21.38% 4.2M

Save your searches and get alerts when important news are released.